Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,983    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,070,832      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,958 Incyte Corp $883,876 Immunome Inc. $112,702 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,958 Incyte Corp $883,876 Immunome Inc. $112,702
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 29 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-10 4 OE $67.81 $678,100 D/D 10,000 435,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-02 4 D $79.86 $682,164 D/D (8,542) 264,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 AS $68.55 $685,477 I/I (10,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-12-24 4 AS $68.71 $687,143 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-29 4 AS $82.67 $688,972 D/D (8,334) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-28 4 AS $82.91 $690,889 D/D (8,333) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-01 4 AS $35.00 $699,920 D/D (20,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-14 4 AS $87.95 $703,600 D/D (8,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-27 4 AS $85.49 $712,388 D/D (8,333) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-10 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-11 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-14 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-15 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-16 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-17 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-13 4 AS $90.45 $723,600 D/D (8,000) 487,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-08-10 4 S $20.20 $724,917 D/D (35,886) 6,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-26 4 AS $60.68 $728,147 I/I (12,000) 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-06-16 4 OE $17.54 $730,822 D/D 41,666 420,250 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-07-18 4 OE $17.54 $730,822 D/D 41,666 420,250 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-08-16 4 OE $17.54 $730,822 D/D 41,666 420,250 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-17 4 OE $17.54 $730,822 D/D 41,666 365,034 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-16 4 OE $17.54 $730,892 D/D 41,670 365,038 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 OE $17.33 $737,859 D/D 42,577 421,161 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29  30   31   32   33   34      
  Page 29 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us